-
Featured Authors
Events
Category Archives: Events
Latest From Events
BIO Official Blogger Roundup
Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Early stage bio and tech tax credits – Maryland style, The Cross-Border Biotech Blog Coca Cola developing bottles using plant-based plastics #bio2012, Biotech Blog Discounted Journal of Commercial Biotechnology subscriptions through June 30 for #bio2012, Biotech Blog BIO 2012: FDA Town Hall, The Campaigns for Modern Medicine Endorser Spotlight: Virginia Biotechnology Association, The Campaigns for Modern Medicine Read More >
Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree
Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree. Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science. Dr. Foti is also known for her work leading AACR’s scientific partnership with Stand Up To Cancer — a charitable initiative that supports Read More >
An Insider’s View of the BioGENEius Challenge
By Erica Hiar, Environics A big highlight every year for many attendees at BIO International Convention is the announcement of the winner of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects. But for me, the true excitement was the ride getting there. Four hundred thirty-five students applied for the U.S. International BioGENEius challenge and hundreds more applied to the Canadian and Western Read More >
We Are BIO
Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >
Jim's Corner
Leave a comment
Email This Post
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders
The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report that show despite the overall lingering uneasiness in the economy, biotech is continuing its growth momentum. The Super Session at the 2012 BIO International Convention was moderated by members of Ernst & Young’s life sciences leadership team: Glen Giovannetti, Gautam Jaggi and Sanjeev Wadhwa; Read More >
